Chemoinformaics analysis of 4,4,8-Trimethyl-non-7-en-2-one
| Molecular Weight | 182.307 | nRot | 5 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 13 |
| Exact Molecular Weight | 182.167 | nRing | 0 |
| Solubility: LogS | -3.589 | nHRing | 0 |
| Solubility: LogP | 3.381 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 35.5114 |
| nHD | 0 | BPOL | 22.9386 |
| QED | 0.604 |
| Synth | 5.452 |
| Natural Product Likeliness | 2.666 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.411 |
| MDCK | 0.0000216 |
| BBB | 0.267 |
| PPB | 0.925084 |
| VDSS | 0.945 |
| FU | 0.108897 |
| CYP1A2-inh | 0.22 |
| CYP1A2-sub | 0.631 |
| CYP2c19-inh | 0.552 |
| CYP2c19-sub | 0.901 |
| CYP2c9-inh | 0.353 |
| CYP2c9-sub | 0.409 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.803 |
| CYP3a4-inh | 0.292 |
| CYP3a4-sub | 0.388 |
| CL | 15.346 |
| T12 | 0.099 |
| hERG | 0.011 |
| Ames | 0.007 |
| ROA | 0.109 |
| SkinSen | 0.148 |
| Carcinogencity | 0.322 |
| EI | 0.114 |
| Respiratory | 0.954 |
| NR-Aromatase | 0.55 |
| Antiviral | No |
| Prediction | 0.626912 |